Translational research and innovative therapies have opened new frontiers in understanding atopic dermatitis (AD), focusing on key areas such as abnormal immune responses, pruritus, microbial ...
Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing ...
This follows its approval for the treatment of adults with prurigo nodularis by the United States (U.S.) Food and Drug Administration (FDA) in August 2024. 14 Prurigo nodularis is a serious skin ...